Release Date: 02/09/16 18:39 Summary: Change of Director's Interest Notice-GBX.AX Price Sensitive: No Download Document 253.46KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%